These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20321948)

  • 1. Regression of OEstrogen Induced Mammary Tumours in Female Rats Following Removal of the Stimulus.
    Noble RL; Collip JB
    Can Med Assoc J; 1941 Jan; 44(1):1-5. PubMed ID: 20321948
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen receptors in rat mammary tissue and plasma concentrations of prolactin during mammary carcinogenesis induced by oestrogen and ionizing radiation.
    Blankenstein MA; Mulder E; Broerse JJ; van der Molen HJ
    J Endocrinol; 1981 Feb; 88(2):233-41. PubMed ID: 7205127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptors in canine mammary tumours.
    Hamilton JM; Else RW; Forshaw P
    Vet Rec; 1977 Sep; 101(13):258-60. PubMed ID: 919278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hormone manipulation on oxidation, reduction and sulphurylation of dehydroepiandrosterone and oestrone in DMBA-induced rat mammary tumours.
    Li K; Chandra DP; Pewnim T; Foo T; Adams JB
    Br J Cancer; 1980 Jan; 41(1):123-9. PubMed ID: 6444830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumours.
    Smith TA; Baluch S; Titley JC; Ormerod MG; Eccles S; Tombs AJ; Leach MO; Griffiths JR; McCready VR
    NMR Biomed; 1993; 6(3):209-14. PubMed ID: 8347455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response.
    Jordan VC; Jaspan T
    J Endocrinol; 1976 Mar; 68(3):453-60. PubMed ID: 1255105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen receptor activity and intranuclear translocation of oestradiol in rat and human mammary tumours.
    Hawkins RA; Scott KM; Freedman B
    J Endocrinol; 1983 Jul; 98(1):91-102. PubMed ID: 6864150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedimentation profiles of the oestrogen receptor from breast tumours of man and rat using vertical-tube rotor centrifugation.
    Freedman B; Hawkins RA
    J Endocrinol; 1980 Sep; 86(3):431-42. PubMed ID: 7191881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumours in rats.
    Kothari A; Borges A; Kothari L
    Eur J Cancer Prev; 1995 Dec; 4(6):497-500. PubMed ID: 8580786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of DNA and lecithin in tissue culture and oestrogen receptor activity in rat mammary tumours dependent on and independent of the ovary.
    Scott AM; Murphy S; Hawkins RA
    J Endocrinol; 1979 May; 81(2):183-98. PubMed ID: 110901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen.
    Müntzing J; Jensen G; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):1-6. PubMed ID: 104546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptors in feline mammary carcinomas.
    Hamilton JM; Else RW; Forshaw P
    Vet Rec; 1976 Dec; 99(24):477-9. PubMed ID: 1014299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the cytoplasmic oestrogen receptor from mammary tumours induced in rats with dimethylbenzanthracene.
    Al-Nuaimi N; Davies P; Griffiths K
    J Endocrinol; 1979 Apr; 81(1):119-30. PubMed ID: 112212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis.
    Hilakivi-Clarke L; Onojafe I; Raygada M; Cho E; Skaar T; Russo I; Clarke R
    Br J Cancer; 1999 Aug; 80(11):1682-8. PubMed ID: 10468283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of endocrine therapy on fibroblast growth factor-like activity in nitrosomethylurea-induced rat mammary tumours.
    Smith J; Chander SK; Baillie R; Coombes RC
    Eur J Cancer; 1993; 29A(15):2125-31. PubMed ID: 7507688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of oestrogen receptors in relation to histopathologic characteristics of DMBA-induced mammary tumours in rats.
    Peña L; Flores JM; González M; Pizarro M; Gómez M
    Exp Pathol; 1991; 43(3-4):221-8. PubMed ID: 1797574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors.
    Nerurkar VR; Ishwad CS; Seshadri R; Naik SN; Lalitha VS
    J Comp Pathol; 1990 Feb; 102(2):191-5. PubMed ID: 2324341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
    Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
    Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.